Bessemer Group
KMTS

Bessemer Group’s Kestra Medical Technologies KMTS Stock Holding History

Bessemer Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9K Buy
451
+102
+29% +$2.4K ﹤0.01% 2153
2025
Q4 		$9K Buy
349
+120
+52% +$3.09K ﹤0.01% 2145
2025
Q3 		$5K Buy
229
+140
+157% +$2.5K ﹤0.01% 2165
2025
Q2 		$1K Hold
89
– – ﹤0.01% 2375
2025
Q1 		$2K Buy
+89
New +$2.04K ﹤0.01% 2293

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bessemer Group's KMTS Position: Q1 2026 in Review

Bessemer Group increased its Kestra Medical Technologies (KMTS) stake by 29% in Q1 2026, buying an estimated $2.4K and bringing the position to 451 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

Bessemer Group first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Bessemer Group held 451 shares of Kestra Medical Technologies worth $9K as of Q1 2026.
  • Bessemer Group bought 102 Kestra Medical Technologies shares in Q1 2026, an estimated $2.4K.
  • Kestra Medical Technologies made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #2153 holding.
  • Bessemer Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.